Table 1. Patients demographic, echographic and computed demography data at baseline and after three months of follow-up.
| Variable | Baseline | Three months | P |
| Age, yrs | 73.7 ± 8.9 | - | |
| Male Gender | 38 (60.3%) | - | |
| CHA2DS2-VASc score | 4.3 ± 1.3 | - | |
| HASBLED Score | 3.4 ± 0.9 | - | |
| Sinus rhythm/AF | 27/36 | 24/39 | 0.42 |
| Hear rate, beats/min | 70 ± 17 | 72 ± 17 | 0.88 |
| BNP levels, pg/mL | 155 ± 107 | 155 ± 150 | 0.85 |
| Loop diuretic treatment, Yes/No | 9/54 | 12/51 | 0.33 |
| Loop diuretic dose, mg | 69 ± 58 | 67 ± 50 | 0.16 |
| TTE measurments | |||
| LVEF, % | 58 ± 7 | 60 ± 5 | 0.78 |
| Peak mitral E-wave, m/s | 84.2 ± 22.7 | 86.7 ± 26 | 0.62 |
| Peak mitral A-wave, m/s | 65.4 ± 18.4 | 68.5 ± 22.2 | 0.66 |
| Peak lateral E' wave, cm/s | 11.1 ± 2.8 | 10 ± 2.9 | 0.15 |
| E/A ratio | 1.1 ± 0.4 | 1.1 ± 0.6 | 0.96 |
| E/E' ratio | 7.9 ± 2.1 | 9.1 ± 3.6 | 0.03 |
| CT left atrial volume, mL | |||
| Overall population | 145.5 ± 55.4 | 144.3 ± 50.5 | 0.30 |
| Sinus rhythm patients | 99.7 ± 19.1 | 103,.8 ± 21 | 0.32 |
| AF patients | 173.2 ± 54.2 | 171.7 ± 48.6 | 0.59 |
Data was presented as Mean ± SD or n (%). AF: atrial fibrillation. BNP: brain natriuretic peptide; CHA2DS2-VASc: cardiac failure, hypertension, age, diabetes, stroke, vascular disease; HASBLED: hypertension, zbnormal renal and liver function, stroke, bleeding, labile INR, elderly, drugs or alcohol; LVEF: left ventricular ejection fraction. TTE: transthoracic echocardiography.